<DOC>
	<DOC>NCT00576862</DOC>
	<brief_summary>The purpose of this trial is to allow patients to continue on HOE 901 until launch and to gather additional long-term safety data.</brief_summary>
	<brief_title>Extension to Study HMR1964A/3011 in Belgium</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Subjects treated with HOE901 and who, in the judgement of the investigator, have benefited from the use of HOE 901 in a previous clinical study with HOE 901. Subjects treated with HOE 901 in a previous clinical study with HOE 901 for whom a change of basal insulin would destabilise glucose metabolism. Subjects who are likely to comply with the investigator's instructions. Evidence of an uncooperative attitude. Subject not on adequate contraception, or who is pregnant, or breast feeding. Subject unable to understand informed consent. Patient receiving or likely to receive HOE901 treatment outside of SPC or PI recommendations. Subject becomes pregnant or is planning to become pregnant.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>